• Madrigal Pharmaceuticals will release second-quarter 2026 financial results on July 30, 2026, before the US market open.
• Management will host a webcast on July 30, 2026 at 8 a.m. ET to discuss financial and operating results; access via https://www.madrigalpharma.com.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Madrigal Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607160800PRIMZONEFULLFEED9762267) on July 16, 2026, and is solely responsible for the information contained therein.